Yes on 4: Massachusetts will vote to create legal access to natural psychedelics this fall
Yes on 4: Massachusetts will vote to create legal access to natural psychedelics this fall
After the recent decision by the FDA to not approve MDMA for the treatment of PTSD, it’s clear that the route to legal access for psychedelics will run through the states for the foreseeable future.
Fortunately, there’s growing momentum behind state-focused efforts to legalize psychedelics. Oregon voters approved Measure 109 in 2020 to create a program for psilocybin services with licensed facilitators at state-approved healing centers. Then Colorado passed Prop 122 in 2022 to remove criminal penalties and create regulated, therapeutic access to four natural psychedelic substances.
This year, it’s Massachusetts’ turn with Question 4. Much like Colorado’s model, Question 4 is a citizen-initiated ballot measure that creates a regulated framework for supervised use with trained facilitators at licensed psychedelic therapy centers and removes criminal penalties for personal use of four natural psychedelic medicines: psilocybin, DMT, ibogaine, and mescaline from non-peyote sources. It requires participants to undergo safety screenings prior to receiving psychedelic therapy services and does not legalize retail sales or storefronts. Learn more and read a summary of the ballot measure here.
Election Day is Tuesday, November 5th, and Question 4 will appear on Massachusetts’ voters ballots this fall. Supporters in Massachusetts and across the country can get involved and support the effort by visiting the campaign website: https://maformentalhealth.org/take-action/
Sign up to get alerts and notifications about opportunities to help with phone banking and other volunteer opportunities. You can also help by spreading the word using their social media toolkit and following the campaign on Twitter (X), Instagram, Facebook, and Youtube.
